Navigation Links
Former CMS Administrator: "'Blunt Instrument' Policies an Increasingly Bad Fit in Era of Personalized Health Care"
Date:5/16/2008

McClellan questions "current pathway of short term patches" in health care

policy reform

ORLANDO, Fla., May 16 /PRNewswire-FirstCall/ -- Recent legislative emphasis on price negotiation and physician reimbursement as a means to reduce health care costs are nothing more than "short term patches" that hold no potential for truly reforming health care, former Centers for Medicare and Medicaid Services (CMS) Administrator Dr. Mark McClellan told hundreds of health care decision makers today in delivering the keynote address at Medco Health Solutions, Inc. (NYSE: MHS) 2008 Drug Trend "Predictions" Symposium.

"We don't seem to be making much progress politically; it's easy to be cynical when it comes to health care," said McClellan, current Director of the Engelberg Center for Health Care Reform and Senior Fellow at the Brookings Institute. "Just focusing on cost reduction doesn't do much to solve the problem of getting more value for what we are spending."

McClellan characterized as unsustainable short-term strategies such as across-the-board reductions in Medicare reimbursement fees for physicians and coverage policies that prevent access to the latest biomedical technologies; yet indicated a shift is clearly afoot within both political parties as candidates move towards a value-based, quality-focused approach to improving care for millions of Americans.

"There simply isn't any additional funding available for new health care programs, but this presents the foundation for changing health care," said McClellan. "Each of the political candidates is demonstrating a new emphasis on improving quality and efficiency of care."

McClellan highlighted improved management of chronic disease
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Retired Supreme Court Justice Sandra Day OConnor and Former House Speaker Newt Gingrich Address Senate Special Committee on Aging, Calling for Urgent Action Against Alzheimers Disease
2. Former GE, Kodak and SGS Executive Dan Kerpelman to Join Bio-Optronics as President and CEO
3. SURGEX(TM) Becomes the Official Sports Nutrition Drink of Former NBA Player Dee Brown and his Edge Basketball Training Facility
4. Campbell Alliance Adds Doug Linton, Former Cardinal Health Executive, to Executive Advisory Group
5. Startech Environmental to Have Three Plasma Converters in Former Pharmaceutical Industry Facility in Puerto Rico
6. DaVita Announces Retirement of Former Chief Medical Officer Charles J. McAllister, M.D.
7. Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
8. UCT Specialties (Formerly Petrarch) Announces the Release of Their New Product Guides for Silanes, Silicones, Platinum Catalyst and Glass Coatings
9. John E. Leonard, Ph.D., Former Biogen Idec Antibody Development Executive, Joins the Scientific Advisory Board of Vaccinex, Inc.
10. Former Manchester City Lord Mayor Has Hope Restored at New Beike Stem Cell Facility
11. Molecular Diagnostics Leader AdvanDx Taps Former Dako Executive Vice President to Lead Global Sales and Marketing Expansion

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...alif., Nov. 6 ,, 3...fer of Qutenza(TM) E.U. Marketing Authorization to...ogress in commercial readiness activities Expande...ctor, Marketing; and Director, Commercial Operatio...ctor and Audit Committee chairman , Upcomin...
(Date:11/6/2009)...if., Nov. 6 Intarcia Therapeutics,...A 650 (DUROS® continuous delivery of exenatid... the Ninth Annual Diabetes Technology Meeting in S....com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,, C...TCA 650 Lowers Plasma Glucose, HbA1c and Reduces W...
(Date:11/5/2009)..., Md., Nov. 5 GenVec, In...results for the third quarter ended September 30, ...$0.04 per share) for the three months ended Septem...n ($0.08 per share) in the comparable quarter of 2... GenVec,s net loss was $14.1 million ($0.15 per sh...
(Date:11/5/2009)...ov. 5 Imagenetix, Inc. (...lliam Spencer, President and CEO of Imagenetix, wi...nual LD MICRO Conference on Thursday, December 3rd...s. ,, About LD MICRO ,, LD MICRO is a by-inv...ng undervalued companies in the micro-cap space. S...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2
...cals,Inc. (Nasdaq: ARNA ) announced today that th...oFin Rodman & Renshaw 9th Annual Healthcare,Confer...e (9:20 a.m.,Pacific Time) at the New York Palace ... Vice President, Finance and Chief Financial Offic...f the company and its clinical,development and dis...
... German . , The automatic molecular assembly an...h start as random mixtures, demonstrates a fundame...on is activated by instructions which are built-in...bit active selection: those in incorrect positions...The molecular-level observation of such self-selec...
...at Purdue University, working with the U.S. Air Fo...t enough to survive the harsh conditions inside je...se to failing and prevent breakdowns. , The devic...as "micro electromechanical systems," or MEMS, whi...ical components on a microscopic scale. , "The ME...
Other Biology Technology:Arena Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 3Evolution in the nanoworld 2Evolution in the nanoworld 3Purdue creating wireless sensors to monitor bearings in jet engines 2Purdue creating wireless sensors to monitor bearings in jet engines 3
(Date:11/9/2009)... of tiny marine plants called phytoplankton are fl...he recent and rapid melting of ice shelves and gla...ble colonisation is having a beneficial impact on ...on sinks to the sea-bed where it can store carbon ... this week in the journal Global Change Biology ,...
(Date:11/9/2009)... journal Naturwissenschaften is publishing a spe...Modern Biology" to commemorate Darwin,s On the Ori...n November 1859. Guest editor and author of the le...lant physiology and evolutionary biology at the Un...s special issue are available free of charge until...
(Date:11/9/2009)... culprit responsible for the rapid, mysterious dea...s been found by collaborating scientists at Rutger...itution (WHOI). This same chemical may hold unexp...covered a previously unknown lipid, or fatty compo...g Emiliania huxleyi , a phytoplankton that plays ...
Breaking Biology News(10 mins):Antarctica glacier retreat creates new carbon dioxide store 2Newly discovered fat molecule: An undersea killer with an upside 2Newly discovered fat molecule: An undersea killer with an upside 3Newly discovered fat molecule: An undersea killer with an upside 4Gene predicts how brain responds to fatigue human study shows 8986 1Gene predicts how brain responds to fatigue human study shows 8986 2NTU and Sembcorp to jointly explore novel waste water treatment technology 49934 1NTU and Sembcorp to jointly explore novel waste water treatment technology 49934 2AUA Foundation announces 2009 Research Scholar Program award winners 49930 1AUA Foundation announces 2009 Research Scholar Program award winners 49930 2AUA Foundation announces 2009 Research Scholar Program award winners 49930 3
...he Standard Scrapie Cell Assay, measures prion inf... rapid way, producing results in less than two wee...allows researchers to quickly distinguish between ...g the new assays, the scientists were able to show...ifferent responses to four different strains of th...
... have proven that by taking a short stretch of DNA...ng antibiotic they can switch off antibiotic resis...ny PBL, the scientists have launched a spin-out co...hnology. , The DNA sequence acts as a decoy, disr...id Dr Michael McArthur from JIC. , We are puttin...
...gsgemeinschaft (DFG, German Research Foundation) w...es, which will receive a total of 74.4 million eur... a lump sum of 20 percent to cover indirect costs ...search Centres (SFBs) will address a range of topi...ibution of oxygen in tropical oceans, and nanoscop...
Other Biology News:Scripps scientists develop new tests that identify lethal prion strains quickly and accurately 2Decoy makes sitting duck of superbugs 2DFG to establish 10 new collaborative research centers 2DFG to establish 10 new collaborative research centers 3DFG to establish 10 new collaborative research centers 4DFG to establish 10 new collaborative research centers 5
Silencer Validated siRNA - with sequence information 20 nmol from Ambion
12(S)-HETE-d8, Deuterium Conjugated/Tagged from Cayman Chemical
Silencer Validated siRNA - with sequence information 5 nmol from Ambion
Silencer Pre-designed siRNA, PAGE purified from Ambion
Biology Products: